PMA device
Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel Control
Medtronic Neuromodulation · Stimulator, Electrical, Implantable, For Incontinence (EZW, Class III) · First FDA decision Jun 26, 2015, newest Jun 26, 2015Fecal incontinence and constipationOveractive bladder and urinary incontinence
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
141
Naming "Verify Evaluation"
MAUDE reports
0
Brand "Verify Evaluation", since 2015
PubMed studies
0
Mentioning "Verify Evaluation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel Control
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P970004-S187 · Decided Jun 26, 2015 · 179 days after receipt · Normal 180 Day Track
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Verify Evaluation", any status and sponsor, newest update first.
VA Office of Research and DevelopmentFederal agency
NCT05990062 · 25 participants (planned) · Start Jun 1, 2025 · Primary completion May 31, 2028
Device: K-Socket-Harness · For: Amputation, Surgical
Sites: Pittsburgh, Pennsylvania
- EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx PopulationsRecruiting
Dana-Farber Cancer InstituteAcademic, hospital or other
NCT06716580 · 1,000 participants (planned) · Start Apr 1, 2025 · Primary completion Sep 1, 2027
Device: Circulating Tumor DNA (ctDNA) Assay · For: Lung Cancer; EGFR Gene Mutation
Sites: Boston, Massachusetts; Brighton, Massachusetts; Methuen, Massachusetts · 6 sites in all
IRCCS San RaffaeleAcademic, hospital or other
NCT06298838 · 0 participants · Start Jun 2026 · Primary completion May 2027
Device: AURA10® Specimen PET/CT imager · For: Prostate Cancer
138 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Verify Evaluation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code EZW
68,097 reports: 34,391 malfunction, 33,649 injury, 34 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0372-2025 · Started Sep 18, 2024 · Posted by FDA Nov 13, 2024
Reason given: The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-0998-2022 · Started Feb 28, 2022 · Posted by FDA Apr 22, 2022
Reason given: There is a software anomaly with the InterStim X Clinician software application with results in the data entered in the Patient Information fields not e retained and a " Data Lost" notification being displayed.
Cause as FDA categorized it: Software Design Change · Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Z-1147-2015 · Started Jan 9, 2015 · Posted by FDA Jun 26, 2015
Reason given: Current labeling indicates that cycling improves device longevity in every programming scenario. However, enabling cycling at certain parameter settings may decrease the device battery longevity. With cycling enabled, longevity estimate displayed on the Model 8840Programmer may be inaccurate.
Cause as FDA categorized it: Other · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Verify Evaluation"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code EZW.
- InterStim Therapy System, Verify Evaluation SystemMedtronic Neuromodulation · PMA 2025
- Axonics Sacral Neuromodulation SystemBoston Scientific Corporation · PMA 2026
- InterStim® Sacral Nerve Stimulation Therapy System (Urinary Control )Medtronic Neuromodulation · PMA 2018
- Neuspera Sacral Neuromodulation (SNM) SystemNeuspera Medical, Inc. · PMA 2026
- Master InterStim® Therapy System, Verify® Evaluation SystemMedtronic Neuromodulation · PMA 2022
- Interstim SystemMedtronic Neuromodulation · PMA 2011
- Medtronic Interstim Tined Lead Models 3889 & 3093Medtronic Neuromodulation · PMA 2007
- Virtis Sacral Neuromodulation SystemCirtec Medical Corporation · PMA 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.